Related Experiment Videos
Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system
1Department of Microbiology, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113. wakita@rinshoken.or.jp
The Journal of Biological Chemistry
|May 16, 1998
Summary
This study developed a novel transgenic mouse model for hepatitis C virus (HCV) infection. The model demonstrates that the host immune response, not viral proteins, drives HCV pathogenesis.
Area of Science:
- Virology
- Immunology
- Genetics
Background:
- Conditional gene expression is crucial for studying gene function.
- Hepatitis C virus (HCV) infection pathogenesis requires further investigation.
- Developing animal models is essential for studying viral diseases.
Purpose of the Study:
- To create an efficient conditional transgenic mouse model for hepatitis C virus (HCV) cDNA activation.
- To investigate the role of host immune response in HCV infection pathogenesis.
Main Methods:
- Utilized the Cre/loxP system for conditional transgene activation of HCV cDNA in mice.
- Administered adenovirus expressing Cre DNA recombinase to induce transgene expression in the liver.
- Analyzed viral protein expression, liver enzyme levels, and immune responses (antibody and cellular).
- Employed CD4 and CD8 positive cell depletion assays to assess immune cell roles.
Main Results:
- Achieved efficient recombination and expression of HCV core, E1, and E2 proteins in mouse liver hepatocytes.
- Observed increased serum core protein and alanine aminotransferase levels post-transgene activation.
- Detected anti-HCV antibody response and identified a critical role for CD4 and CD8 positive T-cells in controlling liver pathology and enzyme level increases.
Conclusions:
- HCV proteins are not directly cytopathic; the host immune response is the primary driver of liver damage in HCV infection.
- This HCV cDNA transgenic mouse model is a valuable tool for studying HCV immune responses and pathogenesis.